Apellis Pharmaceuticals
APLS
#3545
Rank
ยฃ2.15 B
Marketcap
ยฃ17.19
Share price
-2.09%
Change (1 day)
-61.81%
Change (1 year)

Earnings for Apellis Pharmaceuticals (APLS)

Earnings in 2024 (TTM): -ยฃ0.16 Billion

According to Apellis Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.78 Billion. , an increase over its 2023 earnings that were of -ยฃ0.41 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Apellis Pharmaceuticals from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -ยฃ0.16 Billion-62.64%
2023 -ยฃ0.41 Billion-19.19%
2022 -ยฃ0.5 Billion-12.67%
2021 -ยฃ0.57 Billion117.47%
2020 -ยฃ0.27 Billion12.58%
2019 -ยฃ0.24 Billion139.78%
2018 -ยฃ97 Million149.14%
2017 -ยฃ38.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.11 Billion-27.36%๐Ÿ‡บ๐Ÿ‡ธ USA